Amitabh Dube
#956Managing Director
55
Age
25y
Exp
16y
Tenure
4/10
Risk
🎓 Not disclosed · Not disclosed
📜 Executive Education · Tuck School of Business at Dartmouth
🏛️ None
CompensationTBP
Personality
5
Open
7
Cons
4
Extr
5
Agre
3
Neur
Novartis India
· Small Cap
Mature Stable · Bureaucratic
About
Amitabh Dube is the Managing Director of Novartis India, a Small Cap company in the corporate sector with a market cap of ₹2K Cr. A Pragmatic leader with 25 years of experience, he is known for data-driven decision-making and organic builder strategy. Demonstrates a focus on disciplined financial reporting and pharmaceutical governance consistent with global multinational standards.
FAQ
What is Amitabh Dube's leadership style?
Amitabh Dube is classified as a Pragmatic leader. He is data-driven in decision-making, with a impact motivation and steady-marathon pace of execution.
What is Amitabh Dube's educational background?
Amitabh Dube holds a Not disclosed from Not disclosed and a Executive Education from Tuck School of Business at Dartmouth.
Who is the CEO of Novartis India?
Amitabh Dube is the Managing Director of Novartis India. He has been with the company for 16 years and in the current role for 4 years.
Leadership DNA
ArchetypePragmatic
MotivationImpact
CrisisSteady Hand
DecisionData-Driven
GrowthOrganic Builder
PeopleInstitution Builder
InnovationTraditionalist
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployerSteady Employer
BrandTrusted
FocusOperational Excellence
OrientationDeep Specialist
Leadership Evidence
“Demonstrates a focus on disciplined financial reporting and pharmaceutical governance consistent with global multinational standards.”
⚡ Crisis●●●●○
Maintains operational stability and compliance focus within the highly regulated pharmaceutical sector.
🎯 Motivation●●●●○
Focuses on patient access and healthcare solutions, aligning with Novartis' global mission of reimagining medicine.
👥 People●●●○○
Prioritizes long-term organizational health and adherence to global corporate governance standards.
📈 Growth●●●●○
Focuses on optimizing existing portfolios and internal process efficiencies rather than aggressive M&A.
💡 Innovation●●●●○
Novartis India operates primarily as a mature, process-driven entity focused on established therapeutic portfolios rather than pioneering new R&D breakthroughs locally.
🏃 Pace●●●●●
As a mature multinational subsidiary, the company follows a highly predictable, compliance-heavy operational rhythm typical of the pharmaceutical sector.
🌱 Purpose●●●●○
The company consistently emphasizes its global 'reimagining medicine' mandate through structured CSR initiatives focused on healthcare access and community health programs.
🏷️ Brand●●●●●
The brand relies on its long-standing institutional credibility and the global reputation of the parent company for safety and medical reliability.
🤝 Customer●●●●○
The company functions largely as a supplier to hospitals, pharmacies, and institutional distributors rather than engaging in direct-to-consumer retail marketing.
💼 Employer●●●●○
It is recognized for offering a stable, structured, and risk-averse corporate environment typical of established global pharmaceutical MNCs in India.
📋 Mandate
Must pivot its business model to integrate global digital health standards and navigate changing Indian regulatory environments.
🏢 Culture
Global multinational subsidiary structure characterized by rigorous compliance, formal processes, and standardized reporting.
Financials
Revenue FY25₹356 Cr
PAT FY25₹101 Cr
Rev CAGR 5Y-2.8%
OPM26.4%
NPM28.3%
ROE12.9%
ROCE11.7%
P/E21.7
Fwd P/E—
P/B—
D/E0.5
Promoter72.9%
Institutional0.2%
Mkt Cap₹2K Cr
Compensation
To Be Published
Data being verified from audited reports
